Bartlett & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bartlett & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$283K	Hold	3,120	–	–	﹤0.01%	426
2023 Q3	$228K	Sell	3,120 -375	-11%	-$30K	﹤0.01%	431
2023 Q2	$291K	Hold	3,495	–	–	0.01%	408
2023 Q1	$266K	Sell	3,495 -450	-11%	-$37.3K	0.01%	350
2022 Q4	$327K	Hold	3,945	–	–	0.01%	331
2022 Q3	$313K	Hold	3,945	–	–	0.01%	320
2022 Q2	$293K	Hold	3,945	–	–	0.01%	330
2022 Q1	$355K	Hold	3,945	–	–	0.01%	330
2021 Q4	$442K	Hold	3,945	–	–	0.01%	308
2021 Q3	$496K	Hold	3,945	–	–	0.01%	258
2021 Q2	$534K	Hold	3,945	–	–	0.01%	253
2021 Q1	$535K	Hold	3,945	–	–	0.01%	256
2020 Q4	$555K	Hold	3,945	–	–	0.01%	244
2020 Q3	$440K	Sell	3,945 -300	-7%	-$33.6K	0.01%	252
2020 Q2	$475K	Hold	4,245	–	–	0.01%	239
2020 Q1	$329K	Buy	+4,245	New	+$376K	0.01%	258
2019 Q3	$324K	Hold	4,245	–	–	0.01%	286
2019 Q2	$372K	Hold	4,245	–	–	0.01%	219
2019 Q1	$384K	Hold	4,245	–	–	0.01%	215
2018 Q4	$305K	Hold	4,245	–	–	0.01%	226
2018 Q3	$407K	Hold	4,245	–	–	0.02%	213
2018 Q2	$404K	Hold	4,245	–	–	0.02%	213
2018 Q1	$372K	Hold	4,245	–	–	0.02%	212
2017 Q4	$360K	Hold	4,245	–	–	0.01%	217
2017 Q3	$367K	Hold	4,245	–	–	0.02%	210
2017 Q2	$328K	Hold	4,245	–	–	0.01%	216
2017 Q1	$294K	Hold	4,245	–	–	0.01%	224
2016 Q4	$251K	Hold	4,245	–	–	0.01%	232
2016 Q3	$281K	Hold	4,245	–	–	0.01%	225
2016 Q2	$230K	Sell	4,245 -2,100	-33%	-$115K	0.01%	237
2016 Q1	$328K	Hold	6,345	–	–	0.02%	213
2015 Q4	$445K	Hold	6,345	–	–	0.02%	197
2015 Q3	$395K	Hold	6,345	–	–	0.02%	198
2015 Q2	$533K	Hold	6,345	–	–	0.03%	187
2015 Q1	$477K	Hold	6,345	–	–	0.02%	190
2014 Q4	$394K	Hold	6,345	–	–	0.02%	203
2014 Q3	$330K	Hold	6,345	–	–	0.02%	220
2014 Q2	$326K	Sell	6,345 -900	-12%	-$40.6K	0.02%	226
2014 Q1	$344K	Hold	7,245	–	–	0.02%	220
2013 Q4	$314K	Hold	7,245	–	–	0.02%	222
2013 Q3	$312K	Sell	7,245 -750	-9%	-$30.4K	0.02%	220
2013 Q2	$278K	Buy	+7,995	New	+$281K	0.02%	224

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Bartlett & Co's XBI Position: Q4 2023 in Review

Bartlett & Co held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2023 at 3,120 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Bartlett & Co first reported a position in XBI in Q2 2013 and has held it in 42 quarters since. The position peaked at $555K in Q4 2020. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Bartlett & Co held 3,120 shares of State Street SPDR S&P Biotech ETF worth $283K as of Q4 2023.
Bartlett & Co left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2023.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #426 holding.
Bartlett & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 42 quarters since.
Bartlett & Co's State Street SPDR S&P Biotech ETF position peaked at $555K in Q4 2020.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.